Approval Date Drug Name Submission Company
01/03/2022 NOXAFIL; NDA #022003 SUPPL‑30 SCHERING
01/03/2022 CEFEPIME HYDROCHLORIDE; ANDA #065441 SUPPL‑26 ACS DOBFAR
01/03/2022 TRIAZOLAM; ANDA #074224 SUPPL‑10 HIKMA
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United ...
For prescription brand-name drugs, Drugs@FDA typically includes the most recent labeling approved by the FDA (for example, Prescribing Information and FDA- ...